Studies in transgenic models of AD revealed axonal degeneration and defective axonal transport along with spinal cord neuropathology37–41, as well as a progressive gradient of p-tau deposits in humans along the spinal cord with increased p-tau deposition closer to the brain19. This evidence concerns the gene MAPT and Alzheimer disease.